Effects of angiotensin receptor blockers (ARBs) on clinical outcomes of patients with hypertension and COVID-19: A 7-month follow-up cohort study.

Hadadi, Azar; Kazemian, Sina; Shafie, Mahan; Ahmadi, Arezoo; Soleimani, Abbas; Ashraf, Haleh

Hadadi, Azar; Kazemian, Sina; Shafie, Mahan; Ahmadi, Arezoo; Soleimani, Abbas; Ashraf, Haleh.

Afiliación

Hadadi A; Research Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, Iran.
Kazemian S; Cardiac Primary Prevention Research Center, Cardiovascular Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Shafie M; School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ahmadi A; NeuroTRACT Association, Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Soleimani A; Department of Anesthesiology and Critical Care, Sina Hospital, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ashraf H; Department of Cardiology, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.

J Cardiovasc Thorac Res ; 14(4): 253-257, 2022.

Article en En | MEDLINE | ID: mdl-36699557

Palabras clave

Angiotensin-Converting Enzyme Inhibitors; COVID-19; Hypertension; Renin-Angiotensin System; SARS-CoV-2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Idioma: En Revista: J Cardiovasc Thorac Res Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google